ProPhase Labs

Update in progress

PRPH (OTC Markets OTCID)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

ProPhase Labs, Inc. develops and markets drugs, dietary supplements, and genomic services in the United States through Diagnostic Services and Consumer Products. Its TK line includes Legendz XL and Triple Edge XL. The company offers BE-Smart esophageal cancer screening, genome sequencing, DNA Expand (upload DNA data), and LB-1/LB-2 therapies for cancer, inflammatory and memory-related conditions, plus COVID-19 testing. Founded 1989; formerly The Quigley Corporation; based in Garden City, NY.

Company score

Sentiment: 0.40; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.48; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.19; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.18; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.29; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive